Previous close | 0.8300 |
Open | 0.7500 |
Bid | 0.3000 |
Ask | 1.9800 |
Strike | 360.00 |
Expiry date | 2024-01-19 |
Day's range | 0.7500 - 0.8300 |
Contract range | N/A |
Volume | |
Open interest | 833 |
Nektar (NKTR) enters into a deal with Cellular Biomedicine Group to develop NKTR-255 in combination with C-TIL05 to treat advanced NSCLC.
Amazon Pharmacy is just one of the segments of health that the e-retail giant is pursuing.
If you're looking for dividend stocks that can boost your portfolio returns, you should consider high-quality companies that can pay consistent and growing dividends. Two dividend stocks that stand out as strong buys right now are Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO). Here's why these two top-notch dividend stocks are still worth buying, even though they sport premium valuations.